Kedrion reaffirms its commitment for the global eradication of Rh disease
A worldwide initiative for maternal and fetal health launches in Florence, Italy
Kedrion in support of young researchers, the “Guelfo Marcucci” Awards ceremony in Milan
Two scholarships awarded to young researchers in the field of non-oncological hematology
Sant’Antimo site: first phase of investement completed
Opening of the new Quality Control and R&D laboratories
Kedrion to fund an innovative project for the treatment of Hemophilia A
INFOREC wins the Università di Pisa’s PoC grant. Chancellor’s office announces winner on Friday, July 26
Leading medical-scientific event on Hemophilia held in Trieste, Italy
Kedrion-organized congress put replacement therapy, personalization and access to care in the spotlight
From university to business: the second edition of PharmaMark comes to an end
Kedrion partners the Master’s degree that trains future pharmaceutical industry managers
Kedrion seeks innovative “Made in Tuscany” ideas
Company is a key player in “Partnering day” promoted by Invest in Tuscany
June 27 and 28 in Trieste (Italy), a two-day event dedicated to hemophilia
Replacement therapy, personalization and access to treatment are the main themes of the congress organized by Kedrion
Open innovation, Kedrion partners the University of Pisa
Company reaches agreement with the University to finance the development of innovative projects
Kedrion awarded EPD® Product Environmental Certification
First company in the plasma-derivatives industry to obtain this voluntary certification